- Home
- CMBM vs DYAI Comparison
CMBM vs DYAI Comparison
Compare CMBM & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMBM | DYAI |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 30.8M |
| IPO Year | 2019 | 2003 |
Fundamental Metrics
Financial Performance| Metric | CMBM | DYAI |
|---|---|---|
| Price | $1.41 | $0.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 131.6K | 69.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $220,195,000.00 | $3,495,389.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | $18.01 | $92.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.58 |
| 52 Week Low | $0.23 | $0.71 |
| 52 Week High | $6.80 | $1.48 |
Technical Indicators
Market Signals| Indicator | CMBM | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.54 | 47.33 |
| Support Level | $1.10 | $0.73 |
| Resistance Level | $1.81 | $0.87 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 88.00 | 47.63 |
Price Performance
Historical ComparisonAbout CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.